TUMORS OF UNKNOWN ORIGIN

被引:36
作者
GRECO, FA
HAINSWORTH, JD
机构
[1] Vanderbilt University Medical Center, Nashville, Tennessee
[2] Vanderbilt University Medical Center, Nashville, Tennessee
关键词
D O I
10.3322/canjclin.42.2.96
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Although patients with tumors of unknown origin have traditionally been considered to have a very poor prognosis, recent evidence has shown that identifiable subsets of these patients do have responsive tumors. The authors review the classification, clinical characteristics, diagnostic evaluation, and treatment of these tumors.
引用
收藏
页码:96 / 115
页数:20
相关论文
共 72 条
[1]  
Gatter KC, Alcock C, Heryet A, Mason DY, Clinical importance of analysing malignant tumours of uncertain origin with immunohistochemical techniques, Lancet, 1, pp. 1302-1305, (1985)
[2]  
Hales SA, Gatter KC, Heryet A, Mason DY, The value of immunocytochemistry in differentiating high‐grade lymphoma from other anaplastic tumours: A study of anaplastic tumours from 1940 to 1960, Leukemia and Lymphoma, 1, pp. 59-63, (1989)
[3]  
Azar HA, Espinoza CG, Richman AV, Et al., “Undifferentiated” large cell malignancies: An ultrastructural and immunocytochemical study, Hum Pathol, 13, pp. 323-333, (1982)
[4]  
Horning SJ, Carrier EK, Rouse RV, Et al., Lymphomas presenting as histologically unclassified neoplasms: Characteristics and response to treatment, J Clin Oncol, 7, pp. 1281-1287, (1989)
[5]  
Battifora H, Trowbridge IS, A monoclonal antibody useful for the differential diagnosis between malignant lymphoma and nonhematopoietic neoplasms, Cancer, 51, pp. 816-821, (1983)
[6]  
Warnke RA, Gatter KC, Falini B, Et al., Diagnosis of human lymphoma with monoclonal antileukocyte antibodies, New Engl J Med, 309, pp. 1275-1281, (1983)
[7]  
O'Connor DT, Burton D, Deftos LJ, Immunoreactive human chromogranin A in diverse polypeptide hormone producing human tumors and normal endocrine tissues, J Clin Endocrinol Metab, 57, pp. 1084-1086, (1983)
[8]  
Tapia FJ, Polak JM, Barbosa AJ, Et al., Neuron‐specific enolase is produced by neuroendocrine tumours, Lancet, 1, pp. 808-811, (1981)
[9]  
Allhof EP, Proppe KH, Chapman CM, Et al., Evaluation of prostate‐specific acid phosphatase and prostate‐specific antigen, J Urol, 129, pp. 315-318, (1983)
[10]  
Osborn M, Weber K, Biology of disease: Tumor diagnosis by intermediate filament type: A novel tool for surgical pathology, Lab Invest, 48, pp. 372-394, (1983)